Dixon Hubard Feinour & Brown Inc Abb Vie Inc. Transaction History

Dixon Hubard Feinour & Brown Inc

$842 Million
Q2 2022

A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 79,982 shares of ABBV stock, worth $14 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

79,982

Previous 81,734 2.14%

Holding current value

$14 Million

Previous $13.3 Million 7.55%

% of portfolio

1.45%

Previous 1.33%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $241,110 - $306,529	-1,752 Reduced 2.14%	79,982 $12.3 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $65,198 - $80,892	-494 Reduced 0.6%	81,734 $13.3 Million
Q4 2021 Jan 10, 2022	BUY	$107.43 - $135.93 $448,412 - $567,371	4,174 Added 5.35%	82,228 $11.1 Million
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $38,304 - $43,480	360 Added 0.46%	78,054 $8.42 Million
Q2 2021 Aug 23, 2021	BUY	$105.21 - $117.21 $90,796 - $101,152	863 Added 1.12%	77,694 $8.75 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $18,414 - $20,271	180 Added 0.23%	76,831 $8.32 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $78,521 - $92,158	914 Added 1.21%	76,651 $6.71 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $5.06 Million - $6.78 Million	69,032 Added 1029.56%	75,737 $7.33 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $7,611 - $11,539	118 Added 1.79%	6,705 $511,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $21,639 - $27,075	-300 Reduced 4.36%	6,587 $583,000
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $6,298 - $7,572	-100 Reduced 1.43%	6,887 $521,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $24,571 - $31,408	374 Added 5.66%	6,987 $508,000
Q1 2019 May 17, 2019	BUY	$77.14 - $90.79 $39,958 - $47,029	518 Added 8.5%	6,613 $533,000
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $15,569 - $19,202	200 Added 3.39%	6,095 $562,000
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $96,610 - $129,370	-1,050 Reduced 15.12%	5,895 $558,000
Q4 2017 Feb 20, 2018	BUY	$89.56 - $98.21 $8,956 - $9,821	100 Added 1.46%	6,945 $672,000
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $478,123 - $610,710	6,845	6,845 $608,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.

Account

Dixon Hubard Feinour & Brown Inc Abb Vie Inc. Transaction History